和黄医药(00013.HK)：委任郑泽锋担任代理首席执行官

Core Viewpoint - Hutchison China MediTech Limited (00013.HK) announced that its Executive Director Dr. Su Weiguo will temporarily suspend his role as CEO due to health reasons, with the CFO Mr. Zheng Zefeng appointed as acting CEO effective immediately [1] Company Management Changes - The board has appointed Mr. Zheng Zefeng, who is also the Executive Director and CFO, to take on the role of acting CEO during this transition period [1] - Mr. Zheng will oversee the company's daily operations and management to ensure continuity in leadership and decision-making [1]